Finance

Lists
GERN:NASDAQ
Geron Corp
၁.၅၂ US$
၀.၀၀%
(၀.၀၀) 1D
၁.၅၂ US$
+၀.၁၃% (+၀.၀၀၂၀)
After hours
Closed: ဩ ၂၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GERN...
Open
၁.၅၃ US$
High
၁.၅၅ US$
Low
၁.၄၄ US$
Mkt. cap
၉၇.၆၆ ကုဋေ
Avg. vol.
၉.၆၅ သန်း
Volume
၀.၀၀
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၁
Shares outstanding
၆၄.၂၅ ကုဋေ
No. of employees
၂၅၈
Open
၁.၅၃ US$
High
၁.၅၅ US$
Low
၁.၄၄ US$
Mkt. cap
၉၇.၆၆ ကုဋေ
Avg. vol.
၉.၆၅ သန်း
Volume
၀.၀၀
52-wk high
၂.၀၁ US$
52-wk low
၁.၀၄ US$
EPS
-၀.၁၀ US$
Beta
၀.၆၁
Shares outstanding
၆၄.၂၅ ကုဋေ
No. of employees
၂၅၈
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees၂၅၈
Founded၁၉၉၀
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitegeron.com
Analyst ratings
Based on 4 analysts giving stock ratings to GERN in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GERN in the last 3 months.
Highest
Current ၁.၅၂ US$
၆.၀၀ US$ (+၂၉၄.၇၄%)
Average
၄.၃၃ US$ (+၁၈၄.၈၇%)
Lowest
၃.၀၀ US$ (+၉၇.၃၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wedbush
Buy
Reiterated
၆.၀၀ US$
+၂၉၄.၇%
08/06/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
၃.၀၀ US$
+၉၇.၄%
08/05/2026
Emily Bodnar
H.C. Wainwright
Hold
Maintained
-
-
08/05/2026
Gil Blum
Needham
Buy
Maintained
၄.၀၀ US$
+၁၆၃.၂%
08/05/2026
Corinne Johnson
Goldman Sachs
Sell
Reiterated
၁.၀၀ US$
-၃၄.၂%
02/25/2026
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၀၂ US$ / -၀.၀၁ US$
-၁၄၆.၄၀%miss
Revenue / Est. (USD)
၅.၇၅ ကုဋေ / ၅.၅၃ ကုဋေ
+၃.၉၄%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၄.၇၂ ကုဋေ
၄.၈၀ ကုဋေ
၅.၁၈ ကုဋေ
၅.၇၅ ကုဋေ
Cost of goods sold
၂.၂၁ ကုဋေ
၁.၄၉ ကုဋေ
၁.၆၆ ကုဋေ
၃.၁၃ ကုဋေ
Cost of revenue
၂.၂၁ ကုဋေ
၁.၄၉ ကုဋေ
၁.၆၆ ကုဋေ
၃.၁၃ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၉၀ ကုဋေ
၄.၁၇ ကုဋေ
၃.၅၄ ကုဋေ
၃.၈၉ ကုဋေ
Operating expense
၃.၉၀ ကုဋေ
၄.၁၇ ကုဋေ
၃.၅၄ ကုဋေ
၃.၈၉ ကုဋေ
Total operating expenses
၆.၁၁ ကုဋေ
၅.၆၅ ကုဋေ
၅.၂၁ ကုဋေ
၇.၀၁ ကုဋေ
Operating income
-၁.၃၉ ကုဋေ
-၈.၅၁ သန်း
-၂.၃၆ သိန်း
-၁.၂၇ ကုဋေ
Other non operating income
-၁.၆၁ သိန်း
-၇.၀၀ သောင်း
-၇.၄၀ သောင်း
-၉.၀၀ ထောင်
EBT including unusual items
-၁.၈၄ ကုဋေ
-၂.၈၉ ကုဋေ
-၃.၆၄ သန်း
-၁.၆၇ ကုဋေ
EBT excluding unusual items
-၁.၈၄ ကုဋေ
-၁.၁၈ ကုဋေ
-၄.၀၄ သန်း
-၁.၆၈ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၈၄ ကုဋေ
-၂.၈၉ ကုဋေ
-၃.၆၄ သန်း
-၁.၆၇ ကုဋေ
Net profit margin
-၃၉.၀၂%
-၆၀.၁၁%
-၇.၀၃%
-၂၉.၀၂%
Earnings per share
-၀.၀၃
-၀.၀၂
-၀.၀၀
-၀.၀၂
Interest and investment income
၄.၂၆ သန်း
၄.၀၄ သန်း
၃.၄၂ သန်း
၂.၉၇ သန်း
Interest expense
-၈.၆၄ သန်း
-၇.၃၀ သန်း
-၇.၁၅ သန်း
-၇.၁၅ သန်း
Net interest expenses
-၄.၃၈ သန်း
-၃.၂၅ သန်း
-၃.၇၃ သန်း
-၄.၁၈ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၃၈ ကုဋေ
-၈.၄၂ သန်း
-၁.၀၂ သိန်း
-၁.၂၅ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ